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A B S T R A C T
Background: The purpose of this study was to evaluate surgical outcomes of kidney transplantation (KTX) based
on surgeon volume and surgeon experience, and to develop the learning curve model for KTX using the cu-
mulative sum (CUSUM) analysis.
Methods: A retrospective review of 1466 consecutive recipients who underwent KTX between 2010 and 2017
was conducted. In total, 51 surgeons, including certified transplant surgeons, transplant fellows and surgical
residents were involved in these procedures using a standardized protocol. Outcomes were compared based on
surgeon volume (low [1–30] versus high [31≥] volume) and surgeon's type (consultant surgeons, fellows or
residents).
Results: Operative time (129 versus 135 min, P < 0.001) and warm ischemia time (20.9 versus 24.2 min,
P < 0.001) were significantly shorter in the high-volume group, however postoperative outcomes were equal in
both groups. The CUSUM analysis revealed that approximately 30 procedures were necessary to improve sur-
gical skills. In addition, no effect of surgeon's type including consultant surgeons, fellows and residents on
postoperative outcomes was found.
Conclusions: Surgical training in KTX using a standardize protocol can be accomplished with a steep learning
curve without compromising perioperative outcomes under the careful selection of surgeons and procedures.
1. Introduction
Kidney transplantation (KTX) is a complex surgical procedure which
requires properly trained surgeons. However, there can be an area of
tension between educating the trainees during the surgical procedure
and providing patients with the optimal quality of patient care. This
process raises important issues on how to monitor surgeons’ learning
curve and guarantee the quality of surgical procedures.
The cumulative sum (CUSUM) analysis was developed to evaluate
the learning curve for surgical procedures [1,2], and has been adopted
in many fields of surgery [3–5]. In several publications the impact of a
learning curve and surgical training in KTX has been examined [6–8],
concluding that the outcomes of selected trainees was acceptable under
the supervision of experienced surgeons. However, no study has in-
vestigated the impact of a learning curve in KTX using the CUSUM
analysis for surgical skills, or identified the number of procedures for
trainee surgeons must reach in order to adequately and safely perform
KTX.
Our institution is a high-volume center in living kidney donation
and KTX in Western Europe [9], completing more than 1500 living
donor nephrectomies and over 4000 KTX so far. The aim of this study
was to evaluate the learning curve model for KTX using the CUSUM
analysis in a high-volume center. Furthermore, we explored the ne-
cessary number of procedures to improve surgical technique.
2. Materials and methods
2.1. Patients and study design
We conducted a retrospective review of a prospectively collected
database of 1466 consecutive recipients who underwent KTX at our
institution between June 2010 and December 2017. All procedures
were performed by 51 consultant surgeons, transplant fellows or sur-
gical residents during this period. The approval of the Ethics Committee
at our institution was obtained, and the study was conducted in ac-
cordance with the tenets of the Declaration of Helsinki. The work has
https://doi.org/10.1016/j.ijsu.2020.06.047
Received 24 April 2020; Received in revised form 13 June 2020; Accepted 30 June 2020
∗ Corresponding author. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
E-mail address: kotakagi15@gmail.com (K. Takagi).
International Journal of Surgery 80 (2020) 129–134
Available online 11 July 2020
1743-9191/ © 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/by/4.0/).
T
been reported in line with the STROCSS criteria [10]. The present study
was registered at the University Hospital Medical Information Network
(UMIN), registration number UMIN000040213.
2.2. Clinical data
For all enrolled recipients, the following demographic and clinical
data were collected: age, gender, body mass index (BMI), the type of
surgeon (surgical resident, transplant fellow, or consultant surgeon),
the type of donor (living or deceased), number of KTX per patient (first,
second, and third or more), operative time, blood loss, warm ischemia
time (WIT), postoperative complication, and postoperative length of
stay (LOS). Data on postoperative complications included urological
complications, vascular complications, and postoperative bleeding.
Urological complications were defined as ureter stenosis, ureter ne-
crosis, or urine leakage which required percutaneous nephrostomy
placement within 1 year after KTX. Vascular complications included
stenosis or thrombosis of the artery and/or vein. Postoperative bleeding
was defined as any event which required reoperation.
2.3. Surgical technique
The details of our surgical techniques have been described in other
publications [11,12]. Kidneys are implanted into the iliac fossa. The
renal vein is first anastomosed to the external iliac vein with end-to-side
continuous suturing using Prolene 5–0. The renal artery is then ana-
stomosed to the external iliac artery with end-to-side continuous su-
tures with Prolene 5–0. Lastly, the anastomosis between the donor ur-
eter and recipient bladder is performed with an extravesical
anastomosis using an external splint.
2.4. Surgical training system
Surgical residents, transplant fellows and consultant surgeons were
involved in KTX. Surgical residents are defined as trainees in a surgical
specialty for a total of 6 years. They were involved in KTX in their final
years of training using a standardized protocol, and all residents re-
ceived surgical supervision by consultant surgeons. Transplant fellows
who finished all residency pursued additional transplant training for 2
years, and could perform KTX independently. Consultant surgeons who
finished their fellowship were fully qualified to perform KTX in-
dependently. Fellows and consultant surgeons had assistance by re-
sidents, fellows or consultant surgeons on demand. Normally starters
don't perform third or more KTX in patients with atherosclerotic ves-
sels.
2.5. Statistical analysis
Firstly, surgeons at our institution were categorized into eight
groups based on the volume of surgeries performed (groups: group 1
(1–10), group 2 (11–20), group 3 (21–30), group 4 (31–40), group 5
(41–60), group 6 (61–80), group 7 (81–100), and group 8 (101≥));
recipient demographics and perioperative outcomes were then re-
viewed. Secondly, the CUSUM analysis was adopted to identify the
number of surgeries necessary to reach optimal performance by fo-
cusing on WIT. In the CUSUM analysis, the cumulative sums of differ-
ences from the total cohort's mean in each surgeon were calculated and
combined as the mean cumulative sum. Afterwards, outcomes were also
compared between low (1–30) and high (31≥) volume group based on
the CUSUM analysis. Finally, the outcomes between residents, fellows,
and consultant surgeons were compared. In cases where there were
significant confounding factors in preoperative variables, a propensity
score matching (PSM) was performed using a logistic regression model
with one-to-one ratio matching based on propensity scores, as pre-
viously described [13,14]. Data was presented as mean and standard
deviation for continuous variables. Categorical data was presented as
proportions. Differences between groups were assessed using the Mann-
Whitney U test for continuous variables, and Fisher's exact test or chi-
square test for categorical variables. JMP version 11 software (SAS
Institute, Cary, NC) was used for all statistical analyses. A P–value<
0.05 was considered statistically significant.
3. Results
3.1. Study cohort
The overall results of recipient characteristics and outcomes were
summarized in Table 1. Out of 1466 KTX, 962 (66%) were living donors
Table 1


















No. of KTX 1466 304 109 84 78 152 131 132 476
Age (years) 55.1 (14.3) 56.5 (13.3) 55.3 (13.6) 54.3 (14.3) 56.0 (13.9) 56.5 (12.9) 53.2 (15.6) 53.6 (14.6) 54.8 (14.9) 0.55
Gender
Male 929 (63%) 186 (61%) 57 (52%) 55 (65%) 52 (67%) 104 (68%) 95 (73%) 87 (66%) 293 (62%) 0.044
Female 537 (37%) 118 (39%) 52 (48%) 29 (35%) 26 (33%) 48 (32%) 36 (27%) 45 (34%) 183 (38%)
BMI (kg/m2) 26.6 (4.9) 26.5 (4.8) 26.4 (5.0) 26.7 (4.4) 27.3 (4.4) 26.6 (4.8) 26.8 (5.2) 26.7 (5.0) 26.5 (5.0) 0.72
Donor type
Living 962 (66%) 157 (52%) 84 (77%) 54 (64%) 56 (72%) 117 (77%) 93 (71%) 91 (69%) 310 (65%) <0.001
Deceased 504 (34%) 147 (48%) 25 (23%) 30 (36%) 22 (28%) 35 (23%) 38 (29%) 41 (31%) 166 (35%)
Number of KTX
1st 1223 (83%) 262 (86%) 95 (87%) 70 (83%) 68 (87%) 126 (83%) 111 (85%) 103 (78%) 388 (81%) 0.11
2nd 185 (13%) 36 (12%) 11 (10%) 11 (13%) 9 (12%) 23 (15%) 17 (13%) 18 (14%) 60 (13%)
3rd or more 58 (4%) 6 (2%) 3 (3%) 3 (4%) 1 (1%) 3 (2%) 3 (2%) 11 (8%) 28 (6%)
Operative time
(min)
131 (41) 138 (35) 126 (31) 137 (56) 131 (36) 131 (38) 133 (40) 135 (43) 126 (44) <0.001
Blood loss (mL) 349 (432) 361 (381) 314 (370) 410 (600) 331 (365) 291 (324) 331 (499) 429 (482) 344 (444) 0.02
WIT (min) 22.0 (7.4) 25.3 (6.6) 22.2 (7.0) 22.5 (8.0) 20.8 (6.9) 20.7 (7.3) 20.9 (5.9) 20.9 (7.5) 20.9 (7.8) < 0.001
Complication 200 (13.6%) 44 (14.5%) 19 (17.4%) 7 (8.3%) 9 (11.5%) 23 (15.1%) 19 (14.5%) 18 (13.6%) 61 (12.8%) 0.70
Urological 155 (10.6%) 36 (11.8%) 16 (14.7%) 6 (7.1%) 7 (9.0%) 19 (12.5%) 16 (12.2%) 12 (9.1%) 43 (9.0%) 0.52
Vascular 16 (1.1%) 4 (1.3%) 1 (0.9%) 1 (1.2%) 1 (1.3%) 1 (0.7%) 1 (0.8%) 3 (2.3%) 4 (0.8%) 0.94
Bleeding 37 (2.5%) 8 (2.6%) 3 (2.8%) 1 (1.2%) 1 (1.3%) 3 (2.0%) 2 (1.5%) 4 (3.0%) 15 (3.2%) 0.88
LOS (days) 14.2 (10.2) 15.1 (12.4) 14.4 (7.7) 13.8 (7.5) 14.9 (10.1) 14.4 (9.5) 15.1 (13.6) 13.3 (7.1) 13.6 (9.5) 0.13
Data were presented as mean (standard deviation) and numbers (percentages).
KTX kidney transplantation, BMI body mass index, WIT warm ischemia time, LOS length of stay.
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and 504 (34%) were deceased donors. The number of KTX per patient
was as follows: first KTX, 1223 (83%); second, 185 (13%); and third or
more, 58 (4%). Regarding operative outcomes, mean operative time,
blood loss and WIT were 131 min, 349 mL, and 22 min, respectively.
The incidence of postoperative complications included urological
complications (10.6%, n = 155), vascular complications (1.1%,
n = 16), and postoperative bleeding (2.5%, n = 37).
The surgical outcomes of each of the eight groups is shown in
Table 1. Learning curve of operative outcomes including operative
time, blood loss, and WIT were demonstrated in Fig. 1. Operative time
and blood loss varied between the eight groups, however WIT was
significantly shorter in groups where surgeons had performed more
than 30 KTX. The CUSUM analysis of WIT identified the flexion point
after 31 cases, showing dramatic improvement which continues until
50 procedures (Fig. 2). The postoperative outcomes and LOS were not
significantly different between the eight groups.
Outcomes comparing low (1–30) and high (31≥) volume based on
surgeon volume were demonstrated in Table 2. The high-volume group
had significantly shorter operative time (129 versus 135 min,
P < 0.001), WIT (20.9 versus 24.2 min, P < 0.001), and LOS (14.0
versus 14.7 days, P = 0.03) with no significant differences in the in-
cidence of postoperative complications. PSM was performed due to
significant differences among preoperative factors (gender, the type of
donor, and the number of previous KTX). After PSM, two equal groups
of 494 patients were identified. Operative time and WIT were sig-
nificantly shorter in the high-volume group; however postoperative
outcomes were similar in both groups.
The comparison of outcomes between residents (n = 28), fellows
(n = 4), and consultant surgeons (n = 19) was represented in Table 3.
Regarding the operative outcomes, operative time was significantly
shorter in consultant surgeons’ group. In contrast, residents had longest
WIT compared to fellows and consultant surgeons (25.2 versus 21.0
versus 21.5 min, P < 0.01 respectively). However, no significant dif-
ferences were found in postoperative complications and LOS. Con-
sultant surgeons tended to perform more complex cases with third or
more KTX, therefore PSM was adopted combining residents and fellows
into the same group.
The results comparing residents/fellows and consultant surgeons
before and after PSM were depicted in Table 4. After adjusting pre-
operative factors by PSM, consultant surgeons had significantly shorter
operative time (128 versus 135 min, P < 0.01) and WIT (21.8 versus
22.7 min, P < 0.01), however postoperative outcomes were compar-
able among two groups.
Fig. 1. Learning curve of operative time, blood loss, and warm ischemia time in
kidney transplantation between 8 groups: Group 1 (1–10), Group 2 (11–20),
Group 3 (21–30), Group 4 (31–40), Group 5 (41–60), Group 6 (61–80), Group 7
(81–100), and Group 8 (101≥). A. Operative time, B. Blood loss, C. Warm
ischemia time.
Fig. 2. The cumulative sum (CUSUM) analysis of warm ischemia time in kidney
transplantation.
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4. Discussion
The present study shows that surgeon volume did not have any
impact on perioperative short-term outcomes including the incidence of
perioperative complications and LOS in a high-volume center. The
CUSUM analysis for surgical skills reveals dramatic improvement in
WIT after 31 procedures. Furthermore, we found that training residents
and fellows had no effect on perioperative outcomes except for opera-
tive time and WIT.
The effect of surgeon volume has been investigated in many fields of
surgical procedures [15–18]. A nationwide study from Taiwan has
reported that post-transplant outcomes of KTX treated by experienced
surgeons and in high-volume hospitals were superior to those by in-
experienced surgeons and in low-volume hospitals [19]. However, our
results similarly resembled those of a previous report by Wolff et al. [8],
showing no effect of surgeon volume on post-transplant outcomes. Only
operative time and WIT were significant factors associated with dif-
ferences between the low- and high-volume groups but without clinical
consequences.
A previous systematic review examined the effects of hospital vo-
lume of surgery, surgeon volume and specialization on outcome (LOS,
mortality and complication rate) [20]. One Hundred and sixty-three
articles were included in the meta-analysis examining 42 different
surgical procedures, spanning 13 surgical specialities including three
articles about transplantation. Their conclusion was that high surgeon
volume and specialization were associated with improved patient out-
come, while high hospital volume was of limited benefit. A small
number of articles focusing on hospital volume in transplant procedures
only (heart, pancreas, liver and kidney) have been published [21–24].
All 4 articles revealed better postoperative outcome in high-volume
centers. Logistics may play an important and crucial role in better
outcome in high-volume and specialized centers. All personnel (ne-
phrologists, anesthesiologists, OR nurses etc.) are more familiar with
KTX, streamlining the whole perioperative procedure and reducing
human mistakes and medical errors.
Fechner et al. showed that operative time and WIT significantly
decreased after 40 procedures [6]. Our learning curve model using the
CUSUM analysis indicated that WIT improved after 31 procedures. We
believe that WIT is a good indicator which reflects effective surgical
skills and is less affected during difficult cases such as third or more
KTX than operative time or blood loss.
We demonstrate that our training program is safe allowing residents
and fellows to perform KTX properly, and provide patients the highest
quality regardless their experience. It is possible that our standardized
protocol during KTX minimizes potential medical and technical errors.
There are several limitations in the present study that should be
noted. This retrospective study in a single center could have selection
bias and information bias for patients. Normally, residents start their
learning curve with deceased donor KTX due to longer vessels. After
becoming familiar with the surgical steps they will join the living donor
Table 2
Recipient characteristics and outcomes based on surgeons’ volume: overall and propensity score matching cohort.
Before PSM After PSM
Low-volume (1–30) High-volume (31≥) P value Low-volume (1–30) High-volume (31≥) P value
No. of KTX 494 972 494 494
Age (years) 55.9 (13.5) 54.8 (14.6) 0.37 55.9 (13.5) 55.0 (14.5) 0.49
Gender
Male 295 (60%) 634 (65%) 0.04 295 (60%) 295 (60%) 1.00
Female 199 (40%) 338 (35%) 199 (40%) 199 (40%)
BMI (kg/m2) 26.5 (4.8) 26.4 (4.9) 0.61 26.5 (4.8) 26.7 (5.0) 0.60
Donor type
Living 293 (59%) 669 (69%) <0.001 293 (59%) 293 (59%) 1.00
Deceased 201 (41%) 303 (31%) 201 (41%) 201 (41%)
Number of KTX
1st 425 (86%) 798 (82%) 0.026 425 (86%) 425 (86%) 1.00
2nd 58 (12%) 127 (13%) 58 (12%) 58 (12%)
3rd or more 11 (2%) 47 (5%) 11 (2%) 11 (2%)
Operative time (min) 135 (38) 129 (43) <0.001 135 (38) 129 (39) <0.001
Blood loss (mL) 359 (426) 344 (436) 0.15 359 (426) 336 (437) 0.23
WIT (min) 24.2 (7.1) 20.9 (7.4) < 0.001 24.2 (7.1) 20.8 (7.0) < 0.001
Complication 69 (14.0%) 131 (13.5%) 0.80 69 (14.0%) 62 (12.6%) 0.51
Urological 58 (11.7%) 97 (10.0%) 0.30 58 (11.7%) 43 (8.7%) 0.11
Vascular 5 (1.1%) 11 (1.1%) 0.83 5 (1.1%) 7 (1.4%) 0.56
Bleeding 12 (2.4%) 25 (2.6%) 0.87 12 (2.4%) 12 (2.4%) 1.00
LOS (days) 14.7 (10.8) 14.0 (9.9) 0.03 14.7 (10.8) 14.1 (10.6) 0.06
Data were presented as mean (standard deviation) and numbers (percentages).
PSM propensity score matching, KTX kidney transplantation, BMI body mass index, WIT warm ischemia time, LOS length of stay.
Table 3







surgeon (n = 19)
P value
No. of KTX 241 341 884
Age (years) 56.3 (13.1) 55.6 (13.8) 54.6 (14.7) 0.47
Gender
Male 143 (59%) 219 (64%) 567 (64%) 0.37
Female 98 (41%) 122 (36%) 317 (36%)
BMI (kg/m2) 26.6 (4.6) 27.0 (4.8) 26.4 (5.0) 0.06
Donor type
Living 126 (52%) 257 (75%) 579 (66%) < 0.001
Deceased 115 (48%) 84 (25%) 305 (34%)
Number of KTX
1st 211 (88%) 294 (86%) 718 (81%) 0.005
2nd 27 (11%) 39 (12%) 119 (14%)
3rd or more 3 (1%) 8 (2%) 47 (5%)
Operative time
(min)
138 (35) 134 (34) 128 (45) < 0.001
Blood loss (mL) 356 (392) 297 (347) 368 (470) 0.14
WIT (min) 25.2 (6.3) 21.0 (5.9) 21.5 (8.0) < 0.001
Complication 27 (11.2%) 48 (14.1%) 125 (14.1%) 0.47
Urological 23 (9.5%) 40 (11.7%) 92 (10.4%) 0.68
Vascular 1 (0.4%) 5 (1.5%) 10 (1.1%) 0.42
Bleeding 4 (1.7%) 5 (1.5%) 28 (3.2%) 0.13
LOS (days) 14.6 (10.7) 13.8 (9.1) 14.3 (10.5) 0.09
Data were presented as mean (standard deviation) and numbers (percentages).
KTX kidney transplantation, BMI body mass index, WIT warm ischemia time,
LOS length of stay.
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kidney program. Therefore, we performed PSM to reduce the effect of
selection bias. The present analyses do not take into account the prior
experiences of trainees at other centers. Some trainees might have had
experiences in vascular surgery or transplantation at other centers,
however we focused only on procedures at our center, as it is likely that
standardized protocols differ between centers. Moreover, we in-
vestigated the learning curve of KTX focusing on short-term outcomes,
however long-term outcomes such as kidney function and graft survival
were not evaluated. Some studies have reported no impact of surgeon
volume as well as surgeon experience on long-term outcomes after KTX
[6,25], but other studies have demonstrated the negative effect of
surgeon volume on graft function [19]. Therefore it is recommended
that further studies be conducted to clarify the effect of surgeon volume
on the long term outcomes after KTX.
5. Conclusions
The present study demonstrates that surgeon volume did not have
any impact on perioperative outcomes, except for operative time and
WIT in patients undergoing KTX. Approximately 30 procedures are
necessary for surgeons to improve their surgical skills in KTX.
Moreover, no effect of surgeon's type on postoperative outcomes was
shown under the careful selection of the surgeon and a standardized
protocol in KTX.
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